Demonstrates enhanced therapeutic and diagnostic potential of engineered outer membrane vesicles, suggesting innovative applications in medicine.
Genetic engineering reprograms bacterial outer membrane vesicles (OMVs) into modular bionanoplatforms. Surface, cargo, and membrane engineering empower these engineered OMVs for cancer immunotherapy, vaccines, targeted delivery, and diagnostics.
No takes yet. Share an insight, caveat, or question.
Bian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: